How should nausea be assessed in patients receiving chemotherapy?

Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial.

ESMO open·2021

A decade of clinical development of PARP inhibitors in perspective.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

Clinical Outcome of Patients with Advanced Biliary Tract Cancer in a Dedicated Phase I Unit.

Clinical oncology (Royal College of Radiologists (Great Britain))·2017

The Influence of Donor and Recipient Gender Incompatibility on Corneal Transplant Rejection and Failure.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016

An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib.

Targeted oncology·2016

Progress in the treatment of ovarian cancer-lessons from homologous recombination deficiency-the first 10 years.

Annals of oncology : official journal of the European Society for Medical Oncology·2016

Vinorelbine and low-dose cyclophosphamide as maintenance therapy in the treatment of Ewing sarcoma rationale for the international INTER-EWING-1 trial for Ewing sarcoma patients.

Cancer treatment reviews·2026

Is Cytoreductive surgery for unresectable colorectal liver metastases able to improve patient outcome? Results of a pilot prospective study.

Cancer treatment reviews·2026

Chondrosarcoma: A comprehensive review of tumor biology, clinical behavior, and therapeutic advances.

Cancer treatment reviews·2026

Pharmacological prevention of second primary cancers: From chemoprevention to precision cancer interception.

Cancer treatment reviews·2026

Understanding extrapulmonary neuroendocrine carcinomas: Survival, prognosis, and patient quality of life.

Cancer treatment reviews·2026

Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy.

Cancer treatment reviews·2026

Lost in Transition: A Case Study of Oral Baclofen Withdrawal Presenting as Severe Pain.

Cureus·2026

Cell Therapy in Advanced Cirrhosis: From Preclinical Evidence to Clinical Application.

Gastro hep advances·2026

BRCA1 deficiency in oocytes compromises ovulation without exacerbating follicle loss after chemotherapy in mice.

Reproductive biomedicine online·2026

Preclinical evaluation of Ayurveda and Siddha Herbo-mineral formulations in cancer: A scoping review protocol.

PloS one·2026

Inflammatory kinase TBK1 suppresses homologous recombination DNA repair to sensitize tumors to chemotherapy.

Proceedings of the National Academy of Sciences of the United States of America·2026

Haloperidol-Ondansetron versus Dexamethasone-Ondansetron for Prevention of Postoperative Nausea and Vomiting after Laparoscopic Gynecological Surgery: A Randomized Double-Blind Non-Inferiority Trial.

Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses·2026

Related Experiment Videos

How should nausea be assessed in patients receiving chemotherapy?

Related Concept Videos

Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial.

A decade of clinical development of PARP inhibitors in perspective.

Clinical Outcome of Patients with Advanced Biliary Tract Cancer in a Dedicated Phase I Unit.

The Influence of Donor and Recipient Gender Incompatibility on Corneal Transplant Rejection and Failure.

An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib.

Progress in the treatment of ovarian cancer-lessons from homologous recombination deficiency-the first 10 years.

Vinorelbine and low-dose cyclophosphamide as maintenance therapy in the treatment of Ewing sarcoma rationale for the international INTER-EWING-1 trial for Ewing sarcoma patients.

Is Cytoreductive surgery for unresectable colorectal liver metastases able to improve patient outcome? Results of a pilot prospective study.

Chondrosarcoma: A comprehensive review of tumor biology, clinical behavior, and therapeutic advances.

Pharmacological prevention of second primary cancers: From chemoprevention to precision cancer interception.

Understanding extrapulmonary neuroendocrine carcinomas: Survival, prognosis, and patient quality of life.

Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy.

Lost in Transition: A Case Study of Oral Baclofen Withdrawal Presenting as Severe Pain.

Cell Therapy in Advanced Cirrhosis: From Preclinical Evidence to Clinical Application.

BRCA1 deficiency in oocytes compromises ovulation without exacerbating follicle loss after chemotherapy in mice.

Preclinical evaluation of Ayurveda and Siddha Herbo-mineral formulations in cancer: A scoping review protocol.

Inflammatory kinase TBK1 suppresses homologous recombination DNA repair to sensitize tumors to chemotherapy.

Haloperidol-Ondansetron versus Dexamethasone-Ondansetron for Prevention of Postoperative Nausea and Vomiting after Laparoscopic Gynecological Surgery: A Randomized Double-Blind Non-Inferiority Trial.

Related Experiment Videos

How should nausea be assessed in patients receiving chemotherapy?

Related Concept Videos

Related Articles